Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2014

View Archived Issues

New mouse model of ulcerative colitis developed to investigate the ileal epithelial barrier

TNI BioTech forms new subsidiary, Cytocom

Amarantus acquires option to license intellectual property for MANF and CDNF

Takeda files for Japanese approval of trelagliptin succinate for type 2 diabetes

Valneva signs cell-line agreement with Emergent BioSolutions for vaccine development

Tamoxifen found to have potential in treating spinal cord injury

Arena Pharmaceuticals reports discovery of H3 receptor antagonists

Galapagos earns partial milestone payment under osteoarthritis alliance with Servier

Cancer Therapeutics CRC discloses new VEGFR-3 inhibitors for cancer

Yissum Research Development synthesizes cytotoxic vanadium and titanium complexes

AiCuris patents new RT inhibitors for HIV infection

Bayer patent divulges novel BRD4 inhibitors

Bayer Group completes takeover offer for Algeta

Interim phase III data show BPL factor X is well tolerated in patients with hereditary FX deficiency

Sirturo obtains conditional approval in the E.U. for multidrug-resistant tuberculosis

Digital Aria signs agreement to develop RegeneRx's RGN-259 and RGN-137

Independent committee recommends continuation of phase III trial of algenpantucel-L

MolMed requests conditional marketing authorization for TK therapy in the E.U.

Fibrotech completes phase Ia study of FT-011 for diabetic nephropathy

Torii reports results from domestic study of TO-203 for house dust mite-induced allergic rhinitis

Transition from pdFIX to newly developed rFIX, BAX-326, is safe and clinically effective

New grant supports ThromboGenics' research in DME

C3 Jian begins phase II study of C-16G2 for prevention of dental caries

Researchers develop a novel 7-microRNA hematologic cancer panel

Phase IIb/III trial of EPI-743 begins in Leigh syndrome

Cytox initiates clinical trials of mTOR blood tests for dementia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.